摘要
近来随着影像学的发展,急性主动脉夹层更易被确诊,但来自主动脉夹层注册研究的观察显示,约有2/3临床症状可疑的患者,在进行影像学检查后仍不能明确诊断。急性主动脉夹层血清标志物最重要的作用在于快速确诊影像学不能明确的可疑患者,并进行迅速治疗,同时对患者进行初步的预后判断。具有高灵敏度和特异性的血清标志物将在这方面发挥巨大作用,但并非所有标志物都具备这些长处,我们要了解每种指标的优缺点,在临床过程中结合应用,从而更好地指导治疗及判断预后。
Acute aortic dissection （AAD） has become more identifiable by recent advances in imaging methods. According to obser- vations from the IRAD study, two-thirds of patients suspected of AAD cannot be diagnosed after imaging methods. The most important func- tion of AAD biomarkers is the rapid diagnosis of patients that are suspected of needing to undergo rapid imaging, thus allowing for prompt ini- tiation of treatment, and obtaining primary prognosis at the same time. But not all biomarkers have the same efficacy. Therefore, it is important to know the advantages and disadvantages of each index in order to treat patients more effectively.
出处
《心血管病学进展》
CAS
2014年第2期242-245,共4页
Advances in Cardiovascular Diseases
基金
自治区科技支疆(2013911118)
